Maintenance treatment with cetuximab versus observation in RAS wildtype mCRC Presented ByDr Valérie Boige, Institut Gustave Roussy, France TrialPhase 2, PRODIGE 28-time UNICANCER ConferenceASCO GI 2021 12 March, 2021 11:33
